BR112015023621A8 - derivados de meropenem e suas utilizações - Google Patents
derivados de meropenem e suas utilizaçõesInfo
- Publication number
- BR112015023621A8 BR112015023621A8 BR112015023621A BR112015023621A BR112015023621A8 BR 112015023621 A8 BR112015023621 A8 BR 112015023621A8 BR 112015023621 A BR112015023621 A BR 112015023621A BR 112015023621 A BR112015023621 A BR 112015023621A BR 112015023621 A8 BR112015023621 A8 BR 112015023621A8
- Authority
- BR
- Brazil
- Prior art keywords
- meropenem
- derivatives
- meropenem derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361789335P | 2013-03-15 | 2013-03-15 | |
PCT/US2014/028627 WO2014144285A1 (en) | 2013-03-15 | 2014-03-14 | Meropenem derivatives and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112015023621A2 BR112015023621A2 (pt) | 2017-07-18 |
BR112015023621A8 true BR112015023621A8 (pt) | 2018-01-23 |
Family
ID=51537664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015023621A BR112015023621A8 (pt) | 2013-03-15 | 2014-03-14 | derivados de meropenem e suas utilizações |
Country Status (8)
Country | Link |
---|---|
US (4) | US9725451B2 (pt) |
EP (1) | EP2968274B1 (pt) |
JP (2) | JP2016517435A (pt) |
AU (2) | AU2014227737B2 (pt) |
BR (1) | BR112015023621A8 (pt) |
CA (1) | CA2906689A1 (pt) |
HK (1) | HK1219233A1 (pt) |
WO (1) | WO2014144285A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111362239B (zh) * | 2020-03-20 | 2021-07-06 | 辽宁瑞鸥新材料科技有限公司 | 一种用于铝硅系合金半固态制浆的Cs2HPO4气溶胶及其使用方法 |
CN112076161B (zh) * | 2020-08-07 | 2022-10-18 | 安徽康正康仁药业有限公司 | 一种头孢菌素类钠盐与丙磺舒钠组成的复方冻干制剂 |
US11793808B2 (en) | 2021-02-22 | 2023-10-24 | Mannkind Corp. | Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them |
WO2022231998A1 (en) * | 2021-04-27 | 2022-11-03 | Theaprin Pharmaceuticals, Inc. | Compositions comprising cocrystals of acetylsalicylic acid and theanine with tromethamine and methods of use |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA84584B (en) * | 1983-01-28 | 1984-09-26 | Bristol Myers Co | Substituted vinyl cephalosporins |
EP0130119B1 (en) * | 1983-06-23 | 1988-11-09 | Merck & Co. Inc. | (acyloxyalkoxy) carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs, their preparation and pharmaceutical compositions containing said derivatives |
US4914091A (en) | 1984-04-02 | 1990-04-03 | American Cyanamid Company | Esters of cephalosporin derivitives |
JPS6247874A (ja) | 1985-08-27 | 1987-03-02 | Sankyo Seiki Mfg Co Ltd | プログラム動作装置の初期化方法 |
GB9202298D0 (en) * | 1992-02-04 | 1992-03-18 | Ici Plc | Antibiotic compounds |
EP0910351A1 (en) * | 1996-06-27 | 1999-04-28 | G.D. Searle & Co. | Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
KR100589030B1 (ko) | 1998-05-01 | 2006-06-13 | 교토 야쿠힝 고교 가부시키가이샤 | 카르바페넴 유도체, 그 사용 방법 및 그 중간체 화합물 |
JP2000344773A (ja) * | 1998-07-17 | 2000-12-12 | Kyoto Pharmaceutical Industries Ltd | カルバペネム誘導体、およびその用途並びにその中間体化合物 |
JP2000344772A (ja) | 1998-05-01 | 2000-12-12 | Kyoto Pharmaceutical Industries Ltd | カルバペネム誘導体、その用途およびその中間体化合物 |
MXPA03010607A (es) | 2001-05-21 | 2004-04-02 | Kyoto Pharma Ind | Compuesto de carbapenem. |
US20050065141A1 (en) | 2003-07-31 | 2005-03-24 | Odink Debra A. | Carbapenems useful in treating and preventing pulmonary infections, pharmaceutical compositions thereof and modes of administration thereof |
EP2085084A1 (en) | 2008-01-29 | 2009-08-05 | LEK Pharmaceuticals D.D. | Use of inhibitor of beta-lactamases and its combination with beta-lactam antibiotics |
EP2638007A2 (en) * | 2010-11-11 | 2013-09-18 | Redx Pharma Limited | Drug derivatives |
CA2858787C (en) * | 2011-12-15 | 2017-11-21 | Alkermes Pharma Ireland Limited | Prodrugs of tertiary amine compounds |
NZ742004A (en) | 2012-05-03 | 2019-04-26 | Kala Pharmaceuticals Inc | Pharmaceutical nanoparticles showing improved mucosal transport |
-
2014
- 2014-03-14 AU AU2014227737A patent/AU2014227737B2/en active Active
- 2014-03-14 EP EP14762750.9A patent/EP2968274B1/en active Active
- 2014-03-14 WO PCT/US2014/028627 patent/WO2014144285A1/en active Application Filing
- 2014-03-14 JP JP2016502851A patent/JP2016517435A/ja not_active Ceased
- 2014-03-14 CA CA2906689A patent/CA2906689A1/en not_active Abandoned
- 2014-03-14 US US14/777,018 patent/US9725451B2/en active Active
- 2014-03-14 BR BR112015023621A patent/BR112015023621A8/pt not_active Application Discontinuation
-
2016
- 2016-06-23 HK HK16107322.6A patent/HK1219233A1/zh unknown
-
2017
- 2017-07-14 US US15/650,667 patent/US10392388B2/en active Active
-
2018
- 2018-05-01 AU AU2018203005A patent/AU2018203005A1/en not_active Abandoned
-
2019
- 2019-02-13 JP JP2019023946A patent/JP6738918B2/ja active Active
- 2019-07-11 US US16/509,388 patent/US11091487B2/en active Active
-
2021
- 2021-07-07 US US17/369,806 patent/US20210332048A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2968274A1 (en) | 2016-01-20 |
AU2014227737A1 (en) | 2015-10-08 |
AU2018203005A1 (en) | 2018-05-17 |
JP6738918B2 (ja) | 2020-08-12 |
AU2014227737B2 (en) | 2018-05-17 |
US9725451B2 (en) | 2017-08-08 |
US20160039823A1 (en) | 2016-02-11 |
JP2019089829A (ja) | 2019-06-13 |
EP2968274A4 (en) | 2016-08-24 |
EP2968274B1 (en) | 2019-10-16 |
HK1219233A1 (zh) | 2017-03-31 |
US11091487B2 (en) | 2021-08-17 |
CA2906689A1 (en) | 2014-09-18 |
WO2014144285A1 (en) | 2014-09-18 |
US20170349590A1 (en) | 2017-12-07 |
US10392388B2 (en) | 2019-08-27 |
JP2016517435A (ja) | 2016-06-16 |
US20200010470A1 (en) | 2020-01-09 |
US20210332048A1 (en) | 2021-10-28 |
BR112015023621A2 (pt) | 2017-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR302014000302S1 (pt) | Configuração aplicada em pneumático | |
BR302013006428S1 (pt) | Configuração aplicada em pneumático | |
BR302013005076S1 (pt) | Configuração aplicada em pneumático | |
BR302013003723S1 (pt) | Configuração aplicada em pneumático | |
DK3385545T3 (da) | Forbindelsesorgan | |
BR302013005965S1 (pt) | Configuração aplicada em otomana | |
BR302013005487S1 (pt) | Configuração aplicada em aumotóvel | |
DK3087076T3 (da) | Imidazopyrazinonderivater | |
HK1219233A1 (zh) | 美羅培南衍生物及其用途 | |
BR302013005862S1 (pt) | Configuração aplicada em coador | |
TH1401007245B (th) | ผลิตภัณฑ์ดูดซับ | |
TH146512B (th) | ผลิตภัณฑ์ซึมซับ | |
UY4372S (es) | Configuración aplicada en embalaje | |
FR3010330B1 (fr) | Broyeur de vegetaux | |
BR302013001974S1 (pt) | Configuração aplicada em pnemático | |
ES1079187Y (es) | Babero perfeccionado | |
BR302013005268S1 (pt) | Configuração aplicada em muleta axilar | |
UA25711S (uk) | Серветка | |
BR302013004044S1 (pt) | Configuração aplicada em macação | |
BR302013006223S1 (pt) | Configuração aplicada em gabarito | |
BR302013002722S1 (pt) | Configuração aplicada em longarina | |
TH1501001758A (th) | ผลิตภัณฑ์ซึมซับ | |
BR302013002387S1 (pt) | Configuração aplicada em volate | |
BR302013004984S1 (pt) | Configuração aplicada em tamanco | |
BR302013003650S1 (pt) | Configuração aplicada em campímetro |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |